Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
bpV(pic)
80
CHF
CHF 80.00
In stock
AG-CR1-0043-M0055 mgCHF 80.00
AG-CR1-0043-M02525 mgCHF 270.00
Product Details | |
---|---|
Synonyms | Dipotassium bisperoxo (picolinato) oxovanadate (V) |
Product Type | Chemical |
Properties | |
Formula |
K2 [VO(O2)2C6H4NO2] . 2 H2O |
MW | 331.2 . 36.0 |
CAS | 148556-27-8 |
Purity Chemicals | ≥96% (51V-NMR) |
Appearance | Yellow crystalline solid. |
Solubility | Soluble in DMSO or water. NOTE: The product is not stable in water. Decomposition starts immediately after solubilization. Rate of decomposition is slower in dry DMSO. |
Identity | Determined by 51V-NMR. |
InChi Key | ABKLXJHXMGNASO-UHFFFAOYSA-M |
Smiles | O=C1OC[N]2=CC=CC=C12 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent protein phosphotyrosine phosphatase inhibitor [1].
- Insulin mimetic [1].
- Angiogenesis inhibitor [2].
- PTEN inhibitor [3].
Product References
- Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics: B.I. Posner, et al.; J. Biol. Chem. 269, 4596 (1994)
- Peroxovanadium compounds as inhibitors of angiogenesis: C. J. Doillon, et al.; Angiogenesis 3, 361 (1999)
- Bisperoxovanadium compounds are potent PTEN inhibitors: A.C. Schmid, et al.; FEBS Lett. 566, 35 (2004)
- MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies: Y. Li, et al.; J. Clin. Invest. ahead of print 148853 (2021)